巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Xencor

    XNCR
    26.800
    0.990
    3.84%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Xencor - 延遲價格・最後更新於 04/10 12:00
    最高位
    26.980
    最低位
    26.360
    開市價
    --
    前收市價
    25.810
    成交量(千)
    11.07
    成交額(百萬)
    2.36
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    1,599.91
    市盈率
    70.530
    息率
    --
    差價
    --
    52週高低
    43.610 - 19.355
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Xencor
    證券代碼
    XNCR.US
    所屬板塊
    Biotechnology
    公司業務
    Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
    發行量
    59375320
    公司總部
    111 West Lemon Avenue
    公司網址
    http://www.xencor.com
    公司電郵
    info@xencor.com
    公司電話
    +1 626 305-5900
    暫無內容

    關於

    Xencor(XNCR.US)所屬的行業板塊為Biotechnology。
    Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
    詳細公司背景可參考: http://www.xencor.com